Identification of an AP2-family protein that is critical for malaria liver stage development
- PMID: 23144823
- PMCID: PMC3492389
- DOI: 10.1371/journal.pone.0047557
Identification of an AP2-family protein that is critical for malaria liver stage development
Abstract
Liver-stage malaria parasites are a promising target for drugs and vaccines against malaria infection. However, little is currently known about gene regulation in this stage. In this study, we used the rodent malaria parasite Plasmodium berghei and showed that an AP2-family transcription factor, designated AP2-L, plays a critical role in the liver-stage development of the parasite. AP2-L-depleted parasites proliferated normally in blood and in mosquitoes. However, the ability of these parasites to infect the liver was approximately 10,000 times lower than that of wild-type parasites. In vitro assays showed that the sporozoites of these parasites invaded hepatocytes normally but that their development stopped in the middle of the liver schizont stage. Expression profiling using transgenic P. berghei showed that fluorescent protein-tagged AP2-L increased rapidly during the liver schizont stage but suddenly disappeared with the formation of the mature liver schizont. DNA microarray analysis showed that the expression of several genes, including those of parasitophorous vacuole membrane proteins, was significantly decreased in the early liver stage of AP2-L-depleted parasites. Investigation of the targets of this transcription factor should greatly promote the exploration of liver-stage antigens and the elucidation of the mechanisms of hepatocyte infection by malaria parasites.
Conflict of interest statement
Figures
Similar articles
-
Exoerythrocytic Plasmodium parasites secrete a cysteine protease inhibitor involved in sporozoite invasion and capable of blocking cell death of host hepatocytes.PLoS Pathog. 2010 Mar 26;6(3):e1000825. doi: 10.1371/journal.ppat.1000825. PLoS Pathog. 2010. PMID: 20361051 Free PMC article.
-
RNA-Seq Analysis Illuminates the Early Stages of Plasmodium Liver Infection.mBio. 2020 Feb 4;11(1):e03234-19. doi: 10.1128/mBio.03234-19. mBio. 2020. PMID: 32019802 Free PMC article.
-
The Puf-family RNA-binding protein Puf2 controls sporozoite conversion to liver stages in the malaria parasite.PLoS One. 2011;6(5):e19860. doi: 10.1371/journal.pone.0019860. Epub 2011 May 18. PLoS One. 2011. PMID: 21673790 Free PMC article.
-
Plasmodium sporozoites on the move: Switching from cell traversal to productive invasion of hepatocytes.Mol Microbiol. 2021 May;115(5):870-881. doi: 10.1111/mmi.14645. Epub 2020 Dec 5. Mol Microbiol. 2021. PMID: 33191548 Free PMC article. Review.
-
Moving on: How malaria parasites exit the liver.Mol Microbiol. 2024 Mar;121(3):328-340. doi: 10.1111/mmi.15141. Epub 2023 Aug 21. Mol Microbiol. 2024. PMID: 37602900 Review.
Cited by
-
The RNA-binding KH-domain in the unique transcription factor of the malaria parasite is responsible for its transcriptional regulatory activity.PLoS One. 2023 Dec 21;18(12):e0296165. doi: 10.1371/journal.pone.0296165. eCollection 2023. PLoS One. 2023. PMID: 38128025 Free PMC article.
-
DNA-binding protein PfAP2-P regulates parasite pathogenesis during malaria parasite blood stages.Nat Microbiol. 2023 Nov;8(11):2154-2169. doi: 10.1038/s41564-023-01497-6. Epub 2023 Oct 26. Nat Microbiol. 2023. PMID: 37884813 Free PMC article.
-
PfAP2-MRP DNA-binding protein is a master regulator of parasite pathogenesis during malaria parasite blood stages.bioRxiv [Preprint]. 2023 May 24:2023.05.23.541898. doi: 10.1101/2023.05.23.541898. bioRxiv. 2023. PMID: 37293082 Free PMC article. Updated. Preprint.
-
Large DNA fragment knock-in and sequential gene editing in Plasmodium falciparum: a preliminary study using suicide-rescue-based CRISPR/Cas9 system.Mol Cell Biochem. 2024 Jan;479(1):99-107. doi: 10.1007/s11010-023-04711-5. Epub 2023 Apr 1. Mol Cell Biochem. 2024. PMID: 37004637 Free PMC article.
-
Same, same but different: Exploring Plasmodium cell division during liver stage development.PLoS Pathog. 2023 Mar 30;19(3):e1011210. doi: 10.1371/journal.ppat.1011210. eCollection 2023 Mar. PLoS Pathog. 2023. PMID: 36996035 Free PMC article. Review.
References
-
- Hoffman SL, Goh LML, Luke TC, Schneider I, Le TP, et al. (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. Journal of Infectious Diseases 185: 1155–1164. - PubMed
-
- Mueller AK, Labaied M, Kappe SH, Matuschewski K (2005) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433: 164–167. - PubMed
-
- Tarun AS, Dumpit RF, Camargo N, Labaied M, Liu P, et al. (2007) Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J Infect Dis 196: 608–616. - PubMed
-
- White KL, Snyder HL, Krzych U (1996) MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J Immunol 156: 3374–3381. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
